257 related articles for article (PubMed ID: 20473890)
1. Association between toll-like receptor expression and human papillomavirus type 16 persistence.
Daud II; Scott ME; Ma Y; Shiboski S; Farhat S; Moscicki AB
Int J Cancer; 2011 Feb; 128(4):879-86. PubMed ID: 20473890
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2.
Halec G; Scott ME; Farhat S; Darragh TM; Moscicki AB
Int J Cancer; 2018 Dec; 143(11):2884-2891. PubMed ID: 30121951
[TBL] [Abstract][Full Text] [Related]
3. Expression of nucleic acid-sensing Toll-like receptors predicts HPV16 clearance associated with an E6-directed cell-mediated response.
Scott ME; Ma Y; Farhat S; Moscicki AB
Int J Cancer; 2015 May; 136(10):2402-8. PubMed ID: 25346143
[TBL] [Abstract][Full Text] [Related]
4. Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus.
Yu SL; Chan PK; Wong CK; Szeto CC; Ho SC; So K; Yu MM; Yim SF; Cheung TH; Wong MC; Cheung JL; Yeung AC; Li EK; Tam LS
Arthritis Res Ther; 2012 Apr; 14(2):R80. PubMed ID: 22513098
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
Guleria C; Suri V; Kapoor R; Minz RW; Aggarwal R
Gynecol Oncol; 2019 Oct; 155(1):151-160. PubMed ID: 31375269
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Toll-like receptor transcriptome in squamous cell carcinoma of cervix: A case-control study.
Aggarwal R; Misra S; Guleria C; Suri V; Mangat N; Sharma M; Nijhawan R; Minz R
Gynecol Oncol; 2015 Aug; 138(2):358-62. PubMed ID: 26024767
[TBL] [Abstract][Full Text] [Related]
7. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
Hasan UA; Bates E; Takeshita F; Biliato A; Accardi R; Bouvard V; Mansour M; Vincent I; Gissmann L; Iftner T; Sideri M; Stubenrauch F; Tommasino M
J Immunol; 2007 Mar; 178(5):3186-97. PubMed ID: 17312167
[TBL] [Abstract][Full Text] [Related]
8. Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women.
Hasimu A; Ge L; Li QZ; Zhang RP; Guo X
Chin J Cancer; 2011 May; 30(5):344-50. PubMed ID: 21527067
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment.
DeCarlo CA; Rosa B; Jackson R; Niccoli S; Escott NG; Zehbe I
Clin Dev Immunol; 2012; 2012():785825. PubMed ID: 22013487
[TBL] [Abstract][Full Text] [Related]
10. TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections.
Cannella F; Pierangeli A; Scagnolari C; Cacciotti G; Tranquilli G; Stentella P; Recine N; Antonelli G
Immunobiology; 2015 Mar; 220(3):363-8. PubMed ID: 25454809
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the Toll-Like Receptor/Nitric Oxide Signaling Pathway in the Pathogenesis of Cervical Cancer Caused by High-Risk Human Papillomavirus Infection.
Li J; Rao H; Jin C; Liu J
Biomed Res Int; 2017; 2017():7830262. PubMed ID: 28626766
[TBL] [Abstract][Full Text] [Related]
12. Intracellular Toll-Like Receptors Modulate Adaptive Immune Responses in Head and Neck Cancer.
Nayanar SK; Roshan V G D; Surendran S; Kjeller G; Hasséus B; Giglio D
Viral Immunol; 2023 Dec; 36(10):659-668. PubMed ID: 38064542
[TBL] [Abstract][Full Text] [Related]
13. IFNs activate toll-like receptor gene expression in viral infections.
Miettinen M; Sareneva T; Julkunen I; Matikainen S
Genes Immun; 2001 Oct; 2(6):349-55. PubMed ID: 11607792
[TBL] [Abstract][Full Text] [Related]
14. HPV Induces Changes in Innate Immune and Adhesion Molecule Markers in Cervical Mucosa With Potential Impact on HIV Infection.
Britto AMA; Goes LR; Sivro A; Policarpo C; Meirelles ÂR; Furtado Y; Almeida G; Arthos J; Cicala C; Soares MA; Machado ES; Giannini ALM
Front Immunol; 2020; 11():2078. PubMed ID: 33013878
[TBL] [Abstract][Full Text] [Related]
15. [Study on the expression and signification of TLR4/NO pathway in cervical tumorigenesis with high risk HPV infection].
Xiao J; Guo Q; Wang X; Xie F; Zhang H; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2015 Jan; 50(1):41-7. PubMed ID: 25877424
[TBL] [Abstract][Full Text] [Related]
16. Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions.
Yoshida T; Sano T; Kanuma T; Owada N; Sakurai S; Fukuda T; Nakajima T
Int J Gynecol Cancer; 2008; 18(1):121-7. PubMed ID: 17506843
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection.
Lester RT; Yao XD; Ball TB; McKinnon LR; Kaul R; Wachihi C; Jaoko W; Plummer FA; Rosenthal KL
AIDS; 2008 Mar; 22(6):685-94. PubMed ID: 18356597
[TBL] [Abstract][Full Text] [Related]
18. The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers.
Qi SY; Yang MM; Li CY; Yu K; Deng SL
Front Immunol; 2024; 15():1407649. PubMed ID: 38812510
[TBL] [Abstract][Full Text] [Related]
19. HPV: from infection to cancer.
Stanley MA; Pett MR; Coleman N
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1456-60. PubMed ID: 18031245
[TBL] [Abstract][Full Text] [Related]
20. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
